primary open-angle glaucoma

Poor oral health may be associated with POAG
Poor oral health may be associated with POAGRecent tooth loss and periodontal disease have been linked to primary open-angle glaucoma in a large prospective study of male health professionals.
New technology predicts conversion to POAGClinicians can predict which patients with ocular hypertension are most likely to develop primary open-angle glaucoma (POAG) using short-wave automated perimetry, scanning laser polimetry, and confocal laser ophthalmoscopy, as well as the patient’s age, researchers said.
Microstent approval makes big news in glaucoma world
Microstent approval makes big news in glaucoma worldClinicians will soon have another treatment option for their patients with non-severe primary open-angle glaucoma (POAG). A micro invasive glaucoma surgical (MIGS) device (CyPass Micro-Stent, Alcon) has been approved by the FDA for use in patients with mild-moderate PAOG in conjunction with cataract surgery.
Novel gelatin stent works effectively as stand-alone procedureOne-year results are reviewed for use of a novel ab-interno gelatin stent as a stand-alone procedure for patients with mild-to-moderate primary open-angle glaucoma.
Santen to acquire InnFocus, developer of glaucoma drainage implantSanten Pharmaceutical will soon acquire InnFocus, developer of a glaucoma implant device (InnFocus Microshunt), for $225 million, according to a definitive agreement from the two companies.
MICS & MIGS: combined surgery with microstent devicesThe combination of MICS and MIGS can offer an effective surgical treatment for POAG when the reduction of IOP following cataract surgery alone is not sufficient to reduce a patient’s need for glaucoma therapies.
The who, what, when, why and how of selective laser trabeculoplastySelective laser trabeculoplasty is safe and effective for reducing IOP in patients with glaucoma. However, not all patients respond to treatment and its effects are not permanent even in those who respond well.
Fixed combination therapy in glaucoma patientsIn this comparison study, IOP reductions were greater with BTFC than with TTFC and patients on this combination were more likely to achieve and maintain low target pressures. Combined BrTFC and DTFC may also be a more appropriate therapeutic choice for IOP lowering than TTFC and BrTFC, respectively.
Filtration device lowers IOP in patients with PEG and POAGA glaucoma filtration device was equally effective in reducing IOP in pseudoexfoliative glaucoma and primary open-angle glaucoma patients, in a recent small study.
Filtration device lowers IOP in patients with PEG and POAGA glaucoma filtration device was equally effective in reducing IOP in eyes with pseudoexfoliative glaucoma and primary open-angle glaucoma in a recent small study.